XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://www.clinicaltrialsarena.com/uncategorized/newsastrazeneca-begins-phase-iii-study-of-asthma-drug-benralizumab/20%Daily2013-10-31 18:30
https://www.clinicaltrialsarena.com/uncategorized/newscornerstone-begins-phase-ii-study-of-pancreatic-cancer-drug/20%Daily2013-10-31 18:30
https://www.clinicaltrialsarena.com/marketdata/feature-october-top-stories-orexigen-european-marketing-application-contrave/20%Daily2013-10-31 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsalvine-starts-patient-dosing-in-phase-iib-clinical-trial-of-coeliac-disease-drug/20%Daily2013-10-30 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsclovis-starts-patient-enrolment-in-phase-ii-study-of-ovarian-cancer-drug/20%Daily2013-10-30 18:30
https://www.clinicaltrialsarena.com/uncategorized/newspulmatrix-reports-promising-results-from-first-stage-of-phase-ib-study-of-copd-drug/20%Daily2013-10-29 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsoncomed-starts-first-phase-ib-study-of-vantictumab-combination-therapy-for-breast-cancer-treatment/20%Daily2013-10-29 18:30
https://www.clinicaltrialsarena.com/uncategorized/newssunesis-starts-phase-iii-study-of-anti-cancer-drug-vosaroxin/20%Daily2013-10-28 18:30
https://www.clinicaltrialsarena.com/uncategorized/newssophiris-starts-dosing-patients-in-phase-iii-study-of-prostate-drug/20%Daily2013-10-28 18:30
https://www.clinicaltrialsarena.com/uncategorized/newscornerstone-begins-phase-ii-trial-of-lung-cancer-drug/20%Daily2013-10-27 18:30
https://www.clinicaltrialsarena.com/uncategorized/newssynta-releases-encouraging-results-from-galaxy-1-trial-of-lung-cancer-drug-ganetespib/20%Daily2013-10-27 18:30
https://www.clinicaltrialsarena.com/uncategorized/newsauxilium-starts-dosing-in-phase-iia-trial-of-xiaflex-for-cellulite-treatment/20%Daily2013-10-24 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsportola-starts-patient-enrolment-in-phase-iii-study-blood-cancer-drug/20%Daily2013-10-24 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsastrazeneca-starts-phase-iii-trial-lung-cancer-drug-selumetinib/20%Daily2013-10-23 17:30
https://www.clinicaltrialsarena.com/uncategorized/newszs-pharma-completes-patient-enrolment-in-phase-iii-study-of-hyperkalemia-drug/20%Daily2013-10-23 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsangiochem-begins-phase-ii-clinical-trial-of-glioma-drug/20%Daily2013-10-22 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsavanir-begins-patient-enrolment-phase-ii-trial-avp-923-lid-treatment-parkinsons-patients/20%Daily2013-10-22 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsariad-terminates-phase-iii-study-ponatinib-newly-diagnosed-cml-patients/20%Daily2013-10-21 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsinovio-pharmaceuticals-starts-phase-i-clinical-study-of-hepatitis-c-vaccine/20%Daily2013-10-21 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsomeros-reports-additional-positive-data-from-phase-i-study-of-cognition-drug/20%Daily2013-10-20 17:30
https://www.clinicaltrialsarena.com/uncategorized/newspfizer-unveils-top-line-results-from-two-phase-iiib-studies-of-pregabalin-drug/20%Daily2013-10-20 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsd-pharm-begins-phase-ii-study-of-ischemia-drug/20%Daily2013-10-17 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsxeris-begins-dosing-in-phase-ii-study-of-soluble-glucagon/20%Daily2013-10-17 17:30
https://www.clinicaltrialsarena.com/uncategorized/newshanmi-to-start-phase-iib-studies-of-diabetes-drug/20%Daily2013-10-16 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsrebiotix-starts-phase-ii-clinical-study-non-antibiotic-diarrhoea-therapy/20%Daily2013-10-16 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsalcobra-unveils-results-preclinical-studies-cognition-drug/20%Daily2013-10-15 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsinsmed-completes-patient-enrolment-in-phase-ii-study-of-lung-drug/20%Daily2013-10-15 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsflatley-discovery-lab-to-pursue-development-of-fdl169-for-cystic-fibrosis-treatment/20%Daily2013-10-14 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsportola-reports-interim-findings-from-phase-ii-study-of-factor-xa-inhibitor-antidote/20%Daily2013-10-14 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsceltaxsys-begins-patient-enrolment-first-clinical-study-of-cystic-fibrosis-drug/20%Daily2013-10-13 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsmimetogen-starts-phase-iii-dry-eye-syndrome-study/20%Daily2013-10-13 17:30
https://www.clinicaltrialsarena.com/uncategorized/newspromedior-begins-phase-ii-study-of-myelofibrosis-drug/20%Daily2013-10-10 17:30
https://www.clinicaltrialsarena.com/uncategorized/newss-target-achieves-clinical-proof-concept-new-allergy-vaccine-animal-model-asthma/20%Daily2013-10-10 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsmorphotek-begins-phase-i-study-of-solid-tumour-drug-in-paediatric-patients/20%Daily2013-10-09 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsportola-pharmaceuticals-initiates-phase-iii-clinical-study-of-hematologic-cancers-drug-101013/20%Daily2013-10-09 17:30
https://www.clinicaltrialsarena.com/uncategorized/newseleison-begins-phase-iii-trial-of-pancreatic-cancer-drug/20%Daily2013-10-08 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsedimer-starts-phase-ii-trial-of-edi200-treat-xlhed-affected-male-newborns/20%Daily2013-10-08 17:30
https://www.clinicaltrialsarena.com/uncategorized/newspuma-begins-phase-ii-trial-of-cancer-drug-in-solid-tumour-patients/20%Daily2013-10-07 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsgsk-to-submit-regulatory-application-to-ema-for-malaria-vaccine-candidate-in-2014/20%Daily2013-10-07 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsprolongs-sanguinate-found-to-be-safe-well-tolerated-in-phase-i-study/20%Daily2013-10-06 17:30
https://www.clinicaltrialsarena.com/uncategorized/newstakeda-reports-promising-findings-from-phase-iii-study-of-norovirus-vaccine-candidate/20%Daily2013-10-06 17:30
https://www.clinicaltrialsarena.com/uncategorized/newssynergy-to-start-phase-ii-study-of-constipation-drug/20%Daily2013-10-03 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsorexigen-files-european-marketing-authorisation-application-for-weight-loss-drug-contrave/20%Daily2013-10-03 17:30
https://www.clinicaltrialsarena.com/marketdata/feature-september-stories-takeda-type-diabetes-prostate-cancer-vaccine/20%Daily2013-10-02 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsxencor-initiates-dosing-in-phase-iia-rheumatoid-arthritis-study/20%Daily2013-10-02 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsus-fda-ema-accept-omeros-regulatory-applications-eye-drug-for-review/20%Daily2013-10-02 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsalnylam-completes-enrolment-in-phase-ii-transthyretin-mediated-amyloidosis-clinical-trial/20%Daily2013-10-01 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsmerrimack-enrols-last-patient-in-phase-ii-study-of-breast-cancer-drug/20%Daily2013-10-01 17:30